Chai Discovery Collaborates with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery
Chai Discovery and Bristol Myers Squibb partner to advance Artificial Intelligence (AI)-driven antibody discovery, leveraging Chai’s molecular folding and design models to identify antibody candidates.
Digitalization | 21/08/2026 | By News Bureau
Novo Nordisk and AWS Partner to Accelerate AI-Driven Drug Discovery
Novo Nordisk and AWS are partnering to accelerate AI-driven drug discovery, with a new London AI hub and AWS becoming Novo Nordisk’s preferred cloud provider.
Digitalization | 12/08/2026 | By News Bureau
Ministry of Ayush and IndiaAI Sign MoU to Advance AI in Traditional Medicine
The Ministry of Ayush and IndiaAI have partnered to advance AI-driven innovation in traditional medicine, research, digital health and AIKosh integration.
Digitalization | 31/07/2026 | By News Bureau | 122
Bristol Myers Squibb Partners with NVIDIA to Build AI Factory
Bristol Myers Squibb and NVIDIA are building an Artificial Intelligence (AI) factory to accelerate drug discovery using advanced AI infrastructure and proprietary life sciences models.
Digitalization | 22/07/2026 | By News Bureau | 103
The initiative aims to equip pharmaceutical companies, biotech firms and research institutions with AI-driven molecular analysis tools to accelerate drug discovery and advance computational biology research.
Digitalization | 17/07/2026 | By News Bureau | 104
Fischer Medical Ventures Strengthens AI Life Sciences Partnership with Nanyang Biologics
Fischer Medical Ventures and Nanyang Biologics are expanding their strategic collaboration to advance Artificial Intelligence (AI)-powered life sciences research and biotechnology innovation in India.
Digitalization | 14/07/2026 | By News Bureau | 127
Evogene and Tel Aviv University Launch AI Drug Discovery Initiative
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery have launched a joint initiative combining Artificial Intelligence (AI)-driven computational chemistry with advanced experimental capabilities to accelerate small-molecule drug discovery.
Digitalization | 08/07/2026 | By News Bureau | 132
SK Bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
SK bioscience has launched an Artificial Intelligence (AI)-powered initiative to improve vaccine development decisions, supporting next-generation injectable rotavirus vaccines and expanding access in Low- and Middle-Income Countries (LMICs).
Digitalization | 04/07/2026 | By News Bureau | 126
Insilico Medicine and Takeda Collaborate on AI Drug Discovery
Takeda and Insilico Medicine are collaborating to advance Artificial Intelligence (AI)-powered drug discovery, leveraging the Pharma.AI platform to accelerate the development of therapeutics.
Digitalization | 02/07/2026 | By News Bureau | 144
IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform
IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.
Digitalization | 26/06/2026 | By News Bureau | 241
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy